Trials / Completed
CompletedNCT05126316
A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen
Multiple-dose Safety, Pharmacokinetic and Pharmacodynamic Trial, in Subjects With Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of this trial is to learn more about the safety of repeated dosing with Lu AG09222. The trial doctors will keep track of the participant's overall health by asking them how they are and by analyzing blood and urine samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lu AG09222 | Lu AG09222 will be administered per schedule specified in the arm description. |
| DRUG | Placebo | Placebo matching to Lu AG09222 will be administered per schedule specified in the arm description. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-07-12
- Completion
- 2022-08-25
- First posted
- 2021-11-19
- Last updated
- 2022-10-27
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05126316. Inclusion in this directory is not an endorsement.